“a favorable trend”

Although not reaching statistical significance, there was a favorable trend toward slowed global VF MD progression after supplementation began, suggesting a possible neuroprotective effect.

At T1, a favorable trend was observed in the decreasing prevalence of children who did not enjoy any physical activity, while the number of children who enjoy planned physical activity increased.

Neonatal outcomes were generally comparable across groups, though NE showed a favorable trend in reducing the risk of neonatal acidosis (umbilical artery pH OR: 1.25; 95% CI: 1.06-1.54).

After the intervention, the irrational rate of emergency prescriptions decreased significantly and exhibited a favorable trend of continuous improvement.

In the half-meter square agility test, the control group’s time decreased by ≈ 0.72 s (P < 0.05), while the experimental group improved by ≈ 0.59 s (P = 0.075), showing a favorable trend without reaching statistical significance.

The evaluation of the experience with the procedure was predominantly positive in both groups, also demonstrating a favorable trend towards the recommendation.

Although the superiority in PFS in the irAE group tended to attenuate at later landmark time points, a favorable trend was consistently observed across all analyses compared with the non‐irAE group.

Although type 4 tumors showed no significant difference, the MST was 12.9 and 24.4 months for type 4 and non-type 4 tumors, respectively, indicating a favorable trend for non-type 4 tumors.

A significant improvement in health-related quality of life was found at three months in favor of the IG, accompanied by a favorable trend toward enhanced mood.

For all-cause mortality, both DAPA-HF and the EMPEROR trials demonstrated a favorable trend, although reductions were not statistically significant in all subgroups, including non-diabetic patients [ 9 - 11 ].

Although increases in airway volume and surface area were noted, they did not reach statistical significance ( p = 0.327 and p = 0.050, respectively), but suggesting a favorable trend toward airway adaptation.

Although reductions in TNF-α showed a favorable trend, inflammation did not independently predict CAP improvement in this model.

43 Nonetheless, the results indicate a favorable trend toward improved recovery in the lidocaine group.

In that study, the 3-year PFS rate was 66.3% in the group that received DOS therapy and 60.2% in the group that received surgery plus postoperative S-1 therapy, indicating a favorable trend for the preoperative group [ 9 ].

Conclusions Although a favorable trend is emerging, pooled data suggest that within the early treatment period (<12 weeks), BoNT-A may not be more effective than a placebo in reducing pPSS.

Interestingly, reduced doses were associated with a significant reduction in incidental or asymptomatic VTE, and a favorable trend was observed in composite bleeding outcomes, including a statistically significant reduction in combined major and CRNMB events.

While a reduction of ≥ 0.5% is typically considered clinically meaningful and associated with a lower risk of diabetes-related complications [ 193 , 194 ], our findings still indicate a favorable trend in glycemic control.

Among high SDI countries, the United States exhibits a favorable trend, with a net drift of −0.45% (95% CI: −0.69 to −0.21).

The pooled SMD was 1.88 (95% CI: −0.41 to 4.18), indicating a favorable trend toward PRP.

Additionally, while there was a favorable trend toward a reduction in urinary albumin-to-creatinine ratio (UACR) in the ocedurenone group, this change did not reach statistical significance within the study period [ 73 ].

20.2 months; unstratified HR 0.75, 95% CI 0.40–1.41), the serplulimab group had a favorable trend toward improved OS [ 54 ].

Although not statistically significant, this finding suggests a favorable trend regarding the intervention’s effectiveness.

The rising numbers for transmission nodes, inspection nodes, and blockchain security services suggest a favorable trend in respondents’ perceptions of the efficacy of these elements.

When fixing R = 0.95, a favorable trend is a reduction in V with increasing repetitions, reflecting improved precision at a constant success probability.

Among the studies included in this systematic review, only one study failed to achieve statistical significance in adverse event reduction; however, a favorable trend with dose reduction was reported [ 18 ].